Capricor Therapeutics, Inc.
US ˙ NasdaqGS ˙ US14070B3096

SecurityCAPR / Capricor Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership539,232 shares
Latest Disclosed Value $ 16,392,652
Citadel Advisors Llc ownership in CAPR / Capricor Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 539,232 shares of Capricor Therapeutics, Inc. (US:CAPR) valued at $16,392,653 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 901,996 shares of Capricor Therapeutics, Inc.. This represents a change in shares of -40.22% during the quarter. The current value of the position is $14,904,372 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (CAPR) in the form of stock options. The firm currently holds call options representing 564,100 of underlying shares valued at $17,148,640 USD and put options representing 336,500 of underlying shares valued at $10,229,600 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CAPR / Capricor Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 539,232 -362,764 -40.22 16,393 -37.03 0.0023
2026-02-17 2025-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 901,996 751,474 499.25 26,032 2,299.17 0.0039
2025-11-14 2025-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 150,522 150,522 1,085 0.0002
2025-08-14 2025-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -415,951 -100.00 0 -100.00
2025-05-15 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 415,951 150,709 56.82 3,947 7.84 0.0007
2025-02-14 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 265,242 265,242 3,660 0.0006
2024-11-14 2024-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -66,914 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 66,914 36,111 117.23 319 52.63 0.0001
2024-05-15 2024-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 30,803 30,803 209 0.0000
2024-02-14 2023-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -20,861 -100.00 0 -100.00
2023-11-14 2023-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 20,861 -24,787 -54.30 71 -67.43 0.0000
2023-08-14 2023-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 45,648 30,672 204.81 218 246.03 0.0000
2023-05-15 2023-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 14,976 -12,335 -45.16 63 -40.00 0.0000
2023-02-14 2022-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 27,311 -8,927 -24.63 105 -51.61 0.0000
2022-11-14 2022-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 36,238 -10,614 -22.65 217 33.13 0.0000
2022-08-15 2022-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 46,852 -11,755 -20.06 163 -18.91 0.0000
2022-05-16 2022-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 58,607 -21,231 -26.59 201 -14.10 0.0000
2022-02-14 2021-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 79,838 -31,712 -28.43 234 -47.77 0.0000
2021-11-15 2021-09-30 13F CAPRICOR THERAPEUTICS Cmn 14070B309 111,550 41,891 60.14 448 25.49 0.0001
2021-08-16 2021-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 69,659 23,361 50.46 357 64.52 0.0001
2021-05-21 2021-03-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 46,298 9,595 26.14 217 72.22 0.0001
2021-05-17 2021-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 46,298 9,595 217 0.0001
2021-02-16 2020-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 36,703 1,256 3.54 126 -32.26 0.0000
2020-11-16 2020-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 35,447 5,094 16.78 186 32.86 0.0001
2020-08-14 2020-06-30 13F CAPRICOR THERAPEUTICS Cmn 14070B309 30,353 6,474 27.11 140 400.00 0.0000
2020-05-15 2020-03-31 13F CAPRICOR THERAPEUTICS Cmn 14070B309 23,879 12,479 109.46 28 86.67 0.0000
2020-02-14 2019-12-31 13F CAPRICOR THERAPEUTICS Cmn 14070B309 11,400 11,400 15 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 564,100 18.31 17,149 24.62 n/a n/a n/a
2026-02-17 2025-12-31 13F CAPRICOR THERAPEUTICS COM NEW Call 476,800 -36.67 13,760 153.50 n/a n/a n/a
2025-11-14 2025-09-30 13F CAPRICOR THERAPEUTICS COM NEW Call 752,900 73.56 5,428 26.03 n/a n/a n/a
2025-08-14 2025-06-30 13F CAPRICOR THERAPEUTICS COM NEW Call 433,800 286.29 4,308 304.41 n/a n/a n/a
2025-05-15 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 112,300 76.02 1,066 21.02 n/a n/a n/a
2025-02-14 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW Call 63,800 -58.00 880 -61.90 n/a n/a n/a
2024-11-14 2024-09-30 13F CAPRICOR THERAPEUTICS COM NEW Call 151,900 313.90 2,310 1,220.00 n/a n/a n/a
2024-08-14 2024-06-30 13F CAPRICOR THERAPEUTICS COM NEW Call 36,700 60.26 175 12.90 n/a n/a n/a
2024-05-15 2024-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 22,900 59.03 155 121.43 n/a n/a n/a
2024-02-14 2023-12-31 13F CAPRICOR THERAPEUTICS COM NEW Call 14,400 -40.25 70 -14.63 n/a n/a n/a
2023-11-14 2023-09-30 13F CAPRICOR THERAPEUTICS COM NEW Call 24,100 244.29 82 148.48 n/a n/a n/a
2023-08-14 2023-06-30 13F CAPRICOR THERAPEUTICS COM NEW Call 7,000 -82.32 33 -80.24 n/a n/a n/a
2023-05-15 2023-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 39,600 -72.27 167 -69.69 n/a n/a n/a
2023-02-14 2022-12-31 13F CAPRICOR THERAPEUTICS COM NEW Call 142,800 -0.35 551 -35.93 n/a n/a n/a
2022-11-14 2022-09-30 13F CAPRICOR THERAPEUTICS COM NEW Call 143,300 147.92 860 325.74 n/a n/a n/a
2022-08-15 2022-06-30 13F CAPRICOR THERAPEUTICS COM NEW Call 57,800 -22.52 202 -21.09 n/a n/a n/a
2022-05-16 2022-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 74,600 35.88 256 59.01 n/a n/a n/a
2022-02-14 2021-12-31 13F CAPRICOR THERAPEUTICS COM NEW Call 54,900 131.65 161 69.47 n/a n/a n/a
2021-11-15 2021-09-30 13F CAPRICOR THERAPEUTICS Cmn Call 23,700 -58.85 95 -67.80 n/a n/a n/a
2021-08-16 2021-06-30 13F CAPRICOR THERAPEUTICS COM NEW Call 57,600 -24.41 295 -17.37 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CAPRICOR THERAPEUTICS COM NEW Call 76,200 109.34 357 185.60 n/a n/a n/a
2021-05-17 2021-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 76,200 357 n/a n/a n/a
2021-02-16 2020-12-31 13F CAPRICOR THERAPEUTICS COM NEW Call 36,400 -32.09 125 -55.52 n/a n/a n/a
2020-11-16 2020-09-30 13F CAPRICOR THERAPEUTICS COM NEW Call 53,600 19.91 281 36.41 n/a n/a n/a
2020-08-14 2020-06-30 13F CAPRICOR THERAPEUTICS Cmn Call 44,700 206 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 336,500 -31.33 10,230 -27.66 n/a n/a n/a
2026-02-17 2025-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 490,000 -34.28 14,141 163.09 n/a n/a n/a
2025-11-14 2025-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 745,600 146.89 5,376 79.29 n/a n/a n/a
2025-08-14 2025-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 302,000 14.57 2,999 19.87 n/a n/a n/a
2025-05-15 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 263,600 -18.24 2,502 -43.79 n/a n/a n/a
2025-02-14 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 322,400 284.27 4,449 248.67 n/a n/a n/a
2024-11-14 2024-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 83,900 126.15 1,276 625.00 n/a n/a n/a
2024-08-14 2024-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 37,100 77.51 177 24.82 n/a n/a n/a
2024-05-15 2024-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 20,900 -14.34 142 18.49 n/a n/a n/a
2024-02-14 2023-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 24,400 14.02 119 63.01 n/a n/a n/a
2023-11-14 2023-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 21,400 511.43 73 356.25 n/a n/a n/a
2023-08-14 2023-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 3,500 -92.19 17 -91.53 n/a n/a n/a
2023-05-15 2023-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 44,800 -47.04 189 -42.02 n/a n/a n/a
2023-02-14 2022-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 84,600 5.88 327 -31.94 n/a n/a n/a
2022-11-14 2022-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 79,900 -30.64 479 19.15 n/a n/a n/a
2022-08-15 2022-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 115,200 34.42 402 36.73 n/a n/a n/a
2022-05-16 2022-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 85,700 -15.65 294 -1.34 n/a n/a n/a
2022-02-14 2021-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 101,600 -29.15 298 -48.26 n/a n/a n/a
2021-11-15 2021-09-30 13F CAPRICOR THERAPEUTICS Cmn Put 143,400 46.18 576 14.51 n/a n/a n/a
2021-08-16 2021-06-30 13F CAPRICOR THERAPEUTICS COM NEW Put 98,100 98.58 503 117.75 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CAPRICOR THERAPEUTICS COM NEW Put 49,400 -23.77 231 4.05 n/a n/a n/a
2021-05-17 2021-03-31 13F CAPRICOR THERAPEUTICS COM NEW Put 49,400 231 n/a n/a n/a
2021-02-16 2020-12-31 13F CAPRICOR THERAPEUTICS COM NEW Put 64,800 98.77 222 29.82 n/a n/a n/a
2020-11-16 2020-09-30 13F CAPRICOR THERAPEUTICS COM NEW Put 32,600 171 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.